Plain-English translation of NCT05945745 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry study for people with small-cell lung cancer (SCLC). Researchers are collecting genetic information and medical details from patients to better understand what causes the disease to grow quickly and how different people's cancers might respond to treatment. By studying these patterns, the team hopes to develop new, more personalized treatment options.
Small-cell lung cancer is aggressive and patients often relapse quickly after initial treatment. Doctors currently lack reliable tools to predict which patients will respond well to specific therapies. This study aims to identify genetic markers that could help guide treatment decisions and lead to new therapies tailored to individual patients.
You likely qualify if…
You likely don't qualify if…
As a participant, you would be part of a research registry, meaning your medical records, genetic information, and clinical details would be collected and studied by the research team. The study is being conducted at Shanghai Chest Hospital and aims to enroll 500 patients total. The exact visits and procedures would be explained during the consent process, but your involvement would help researchers build a comprehensive database to understand your disease better and improve future treatment options.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China
Enrollment target
~500 participants
Started
January 2016
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xiaomin Niu
Shanghai Chest Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.